Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults

    Access Status
    Fulltext not available
    Authors
    Zhou, Z.
    Ofori-Asenso, R.
    Curtis, A.J.
    Breslin, M.
    Wolfe, R.
    McNeil, J.J.
    Murray, A.M.
    Ernst, M.E.
    Reid, Christopher
    Lockery, J.E.
    Woods, R.L.
    Tonkin, A.M.
    Nelson, M.R.
    Date
    2020
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Zhou, Z. and Ofori-Asenso, R. and Curtis, A.J. and Breslin, M. and Wolfe, R. and McNeil, J.J. and Murray, A.M. et al. 2020. Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults. Journal of the American College of Cardiology. 76 (1): pp. 17-27.
    Source Title
    Journal of the American College of Cardiology
    DOI
    10.1016/j.jacc.2020.05.016
    ISSN
    0735-1097
    Faculty
    Faculty of Health Sciences
    School
    School of Public Health
    URI
    http://hdl.handle.net/20.500.11937/80043
    Collection
    • Curtin Research Publications
    Abstract

    © 2020 American College of Cardiology

    Foundation Background: There is clinical uncertainty regarding the benefits and harms of prescribing statins in healthy subjects ≥70 years of age. Objectives: The aim of this study was to examine the association among statins, dementia-free and disability-free survival, and cardiovascular disease (CVD) among healthy older adults using data from the ASPREE (Aspirin in Reducing Events in the Elderly) trial. Methods: ASPREE was a randomized trial of 19,114 community-dwelling persons in Australia and the United States ≥65 years of age and free of documented CVD, dementia, and disability. Data were collected for those ≥70 years of age, and participants who took statins at baseline were compared with those who did not using Cox proportional hazards regression with inverse probability weighting. The primary outcome, referred to as “disability-free survival,” was a composite of all-cause mortality, dementia, or persistent physical disability. Other outcomes included the individual components of the composite outcome, major adverse cardiovascular events, fatal CVD, myocardial infarction, and stroke. Results: Of the 18,096 included participants (median age 74.2 years, 56.0% women), 5,629 took statins at baseline. Over a median follow-up period of 4.7 years, baseline statin use was not associated with disability-free survival or with the risk for all-cause mortality or dementia. However, it was associated with lower risks for physical disability and all cardiovascular outcomes. Conclusions: Among healthy community-dwelling adults ≥70 years of age, statin use may be beneficial for preventing physical disability and CVD but not beneficial for prolonging disability-free survival or avoiding death or dementia. Future clinical trials are needed to confirm these findings.

    Related items

    Showing items related by title, author, creator and subject.

    • Effect of aspirin on disability-free survival in the healthy elderly
      McNeil, J.; Woods, R.; Nelson, M.; Reid, Christopher; Kirpach, B.; Wolfe, R.; Storey, E.; Shah, R.; Lockery, J.; Tonkin, A.; Newman, A.; Williamson, J.; Margolis, K.; Ernst, M.; Abhayaratna, W.; Stocks, N.; Fitzgerald, S.; Orchard, S.; Trevaks, R.; Beilin, L.; Donnan, G.; Gibbs, P.; Johnston, C.; Ryan, J.; Radziszewska, B.; Grimm, R.; Murray, A. (2018)
      Background: Information on the use of aspirin to increase healthy independent life span in older persons is limited. Whether 5 years of daily low-dose aspirin therapy would extend disabilityfree life in healthy seniors ...
    • Effect of aspirin on all-cause mortality in the healthy elderly
      McNeil, J.; Nelson, M.; Woods, R.; Lockery, J.; Wolfe, R.; Reid, Christopher; Kirpach, B.; Shah, R.; Ives, D.; Storey, E.; Ryan, J.; Tonkin, A.; Newman, A.; Williamson, J.; Margolis, K.; Ernst, M.; Abhayaratna, W.; Stocks, N.; Fitzgerald, S.; Orchard, S.; Trevaks, R.; Beilin, L.; Donnan, G.; Gibbs, P.; Johnston, C.; Radziszewska, B.; Grimm, R.; Murray, A. (2018)
      Background: In the primary analysis of the Aspirin in Reducing Events in the Elderly (ASPREE) trial, now published in the Journal, we report that the daily use of aspirin did not provide a benefit with regard to the primary ...
    • Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study
      McNeil, J.; Woods, R.; Nelson, M.; Murray, A.; Reid, Christopher; Kirpach, B.; Storey, E.; Shah, R.; Wolfe, R.; Tonkin, A.; Newman, A.; Williamson, J.; Lockery, J.; Margolis, K.; Ernst, M.; Abhayaratna, W.; Stocks, N.; Fitzgerald, S.; Trevaks, R.; Orchard, S.; Beilin, L.; Donnan, G.; Gibbs, P.; Johnston, C.; Grimm, R.; ASPREE Investigator Group (2017)
      Background: There are no primary prevention trials of aspirin with relevant geriatric outcomes in elderly people. ASPirin in Reducing Events in the Elderly (ASPREE) is a placebo-controlled trial of low-dose aspirin that ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.